John Furey — Chief Operating Officer at Spark Therapeutics

Mr. John Furey has been Chief Operating Officer at Spark Therapeutics, Inc. since December 5, 2016. Mr. Furey is responsible for global commercial operations, medical affairs, technology development and technical operations at Spark. Mr. Furey has 25 years of experience in developing and implementing operational strategies and leading commercial and technical teams. Mr. Furey served as Head of Global Operations of Baxter BioScience. Prior to joining Spark Therapeutics, he served as Senior Vice President and Head of Global Operations for Baxalta Incorporated, where he directed manufacturing, quality, engineering and process development. Mr. Furey actively managed a$2.5 billion production budget across Baxalta's global network and led a first-in-class supply chain organization for rare diseases. He led the team that coordinated and delivered the successful establishment of Baxalta through a spin out from Baxter and led the Baxter Vaccine inline business to realize significant top line and bottom line growth. He also spent two years in China as general manager of Pfizer's vaccine business unit following a role with responsibility for global pricing and reimbursement at Pfizer Vaccines. In these roles, Mr. Furey gained extensive experience in pipeline development and global product launches. Earlier in his career, he held both commercial and operations positions of increasing scope and responsibility with Pfizer and Wyeth Pharmaceuticals. Mr. Furey holds an executive M.B.A. from St. Joseph's University, Philadelphia, a B.S. from Trinity College, Dublin and a diploma in Environmental Health from the Dublin Institute of Technology.